This study investigated the 1-year incidence of extrapyramidal symptoms (EPS), as well as the incremental economic burden, in patients with schizophrenia initiating atypical antipsychotics.
Carole Dembek, MS
Advertisement
Articles by Carole Dembek, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Andes Hantavirus FAQs: What to Know as Quarantined Cruise Passengers Return Home
2
New Therapies Offer Hope for Vitiligo, an Often Misunderstood and Undertreated Disease
3
FDA Issues Complete Response Letter for Cingulate's Once-Daily ADHD Drug CTx-1301
4
Rituximab Suppresses Clinical Relapses, MRI Activity in Pediatric MS
5